title: Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.
abstract: Community-acquired extended-spectrum beta-lactamase E coli (ESBLEC) have not been previously described in Honolulu. Its emergence as a community-acquired pathogen is concerning. This case series describes three patients who were diagnosed with community-acquired ESBLEC bacteriuria in 2010.
authors.affiliation: University of Hawai'i John A. Burns School of Medicine, Honolulu, USA.
authors.forename: Reid R
authors.initials: RR
authors.lastname: Hoshide
authors.forename: Heath
authors.initials: H
authors.lastname: Chung
authors.forename: Jinichi
authors.initials: J
authors.lastname: Tokeshi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary; D001437:Bacteriuria / Q000188:drug therapy / Q000453:epidemiology*; D002939:Ciprofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology*; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D006254:Hawaii / Q000453:epidemiology; D006801:Humans; D008297:Male; D000077731:Meropenem; D008875:Middle Aged; D009582:Nitrofurantoin / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D013845:Thienamycins / Q000494:pharmacology / Q000627:therapeutic use; D001618:beta-Lactamases / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D013845:Thienamycins; D002939:Ciprofloxacin; D019980:Amoxicillin-Potassium Clavulanate Combination; D009582:Nitrofurantoin; D001618:beta-Lactamases; D000077731:Meropenem